(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s Annual Meeting in May 2020, an Educational Symposium was convened on August 8-10. In a session entitled “Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate Cancer”, Dr. Carmel Jo Pezaro from Weston Park Hospital, Sheffield Teach Hospitals NHS Foundation Trust presented a plenary talk on selecting patients with metastatic castration sensitive prostate cancer (mCSPC) for chemotherapy.